OFIX (STOCKS)
Orthofix Medical Inc. Common Stock (DE)
$9.230000
-0.180000 (-1.91%)
Prev close: $9.410000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Medical Specialties
- CEO
- Massimo Calafiore
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $372.69M
- Employees
- 1,616
- P/E (TTM)
- -6.14
- P/B (TTM)
- 0.87
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
4
Strong Buy
4
Buy
3
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Mar 2026 (Q1)
|
$-0.13 | $-0.69 | +0.5636 | +81.26% |
|
Dec 2025 (Q4)
|
$-0.06 | $-0.32 | +0.2562 | +81.02% |
|
Sep 2025 (Q3)
|
$-0.57 | $-0.41 | -0.1552 | -37.42% |
|
Jun 2025 (Q2)
|
$-0.45 | $-0.50 | +0.0498 | +9.96% |
Financial Statements
| Revenues | $825.37M |
| Benefits Costs and Expenses | $884.89M |
| Cost Of Revenue | $241.43M |
| Costs And Expenses | $884.89M |
| Gross Profit | $583.94M |
| Operating Expenses | $630.94M |
| Selling, General, and Administrative Expenses | $556.26M |
| Depreciation and Amortization | $56.38M |
| Research and Development | $61.40M |
| Operating Income/Loss | -$46.99M |
| Income/Loss From Continuing Operations After Tax | -$60.01M |
| Income/Loss From Continuing Operations Before Tax | -$59.51M |
| Income Tax Expense/Benefit | $495.00K |
| Income Tax Expense/Benefit, Deferred | -$129.00K |
| Interest Income/Expense After Provision For Losses | -$19.15M |
| Interest Income/Expense Operating, Net | -$18.65M |
| Net Income/Loss | -$60.01M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$60.01M |
| Net Income/Loss Available To Common Stockholders, Basic | -$60.01M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Provision For Loan, Lease, And Other Losses | $508.00K |
| Basic Earnings Per Share | -$1.50 |
| Diluted Earnings Per Share | -$1.50 |
| Basic Average Shares | 119,851,345 |
| Diluted Average Shares | 119,851,345 |
| Assets | $886.60M |
| Current Assets | $461.52M |
| Inventory | $177.82M |
| Other Current Assets | $283.70M |
| Noncurrent Assets | $425.08M |
| Fixed Assets | $125.33M |
| Intangible Assets | $69.34M |
| Other Non-current Assets | $230.42M |
| Liabilities | $451.42M |
| Current Liabilities | $161.03M |
| Accounts Payable | $54.69M |
| Other Current Liabilities | $106.35M |
| Noncurrent Liabilities | $290.38M |
| Equity | $435.19M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $435.19M |
| Liabilities And Equity | $886.60M |
| Net Cash Flow From Operating Activities | $34.13M |
| Net Cash Flow From Operating Activities, Continuing | $34.13M |
| Net Cash Flow From Investing Activities | -$38.38M |
| Net Cash Flow From Investing Activities, Continuing | -$38.38M |
| Net Cash Flow From Financing Activities | $63.84M |
| Net Cash Flow From Financing Activities, Continuing | $63.84M |
| Net Cash Flow | $59.59M |
| Net Cash Flow, Continuing | $59.59M |
| Comprehensive Income/Loss | -$60.77M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$57.31M |
| Other Comprehensive Income/Loss | -$46.69M |
| Other Comprehensive Income/Loss Attributable To Parent | $2.70M |